Company intelligence / Profile preview

Chardan Healthcare Acquisition Corp

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Chardan Healthcare Acquisition Corp was a special purpose acquisition company formed to complete a merger or similar business combination in the healthcare industry. It raised capital in 2018 and operated as a publicly traded SPAC rather than as a drug developer, service provider, or operating biotech company. In October 2019, CHAC completed its business combination with BiomX Ltd., a microbiome company developing natural and engineered phage therapies, and the combined company was renamed BiomX Inc. As a result, Chardan Healthcare Acquisition Corp no longer operates as an independent company.

Industry: Investors

Partnerships

BiomX

Beyond the preview

Go deeper on Chardan Healthcare Acquisition Corp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chardan Healthcare Acquisition Corp.

Explore the full profile